Benjamin Cohen - Y-Brush | LinkedIn (original) (raw)

About

I thrive on building bold, innovative and result-oriented companies.

Growing…

Articles by Benjamin

Activity

Experience & Education

View Benjamin’s full experience

See their title, tenure and more.

Publications

J Clin Virol. 2013 Sep;58(1):114-9. doi: 10.1016/j.jcv.2013.05.025. Epub 2013 Jul 3. Sep 2013

BACKGROUND:
The emergence of novel A(H1N1)pdm2009 virus threatened to lead to frequent severe manifestations.
OBJECTIVES:
To describe the clinical, virological, and biological characteristics of the disease and identify the factors associated with severe presentations.
STUDY DESIGN:
This prospective multicenter study recruited consecutive hospitalized patients with confirmed A(H1N1)pdm2009 disease. Clinical, virological and biological assessments were carried out at inclusion and…
BACKGROUND:
The emergence of novel A(H1N1)pdm2009 virus threatened to lead to frequent severe manifestations.
OBJECTIVES:
To describe the clinical, virological, and biological characteristics of the disease and identify the factors associated with severe presentations.
STUDY DESIGN:
This prospective multicenter study recruited consecutive hospitalized patients with confirmed A(H1N1)pdm2009 disease. Clinical, virological and biological assessments were carried out at inclusion and 30 days post-inclusion. Disease manifestations were assessed by an adjudication committee using pre-identified definitions of complications and severity scores.
RESULTS:
The study analyzed from November 30th, 2009 to February 8th, 2010, 40 hospitalized patients, 21 children and 19 adults. Eighteen (45%) were considered to have severe presentations. Except age, main characteristics in children and adults did not differ. The majority (18/21) of children and all adults had a respiratory presentation; extra-respiratory manifestations tended to be more frequent in children (12 vs. 6, P=0.10). Two children against 5 adults presented acute respiratory distress syndrome (ARDS, P=0.23), but more children suffered respiratory failure (7 vs. 1, P=0.046) without ARDS. At day 30, one death had occurred in each group. The main factor associated with non-severe presentation was an early (<48 h) implementation of oseltamivir treatment (P=0.038).
CONCLUSIONS:
Although the study failed to achieve its main objective, due mainly to the difficulty of carrying a study of this nature in the midst of a pandemic, it allowed the description of a panel of unusual and complicated forms and confirmed the added value of early oseltamivir treatment in limiting severity in hospitalized children and adults.
Other authors

Projects

Jun 2016

Co-organizer for the Startup Weekend Lyon Sciences 2016 event

Jan 2016

Member of the steering group.

Apr 2015

Gareremix is a project organized by GrandLyon, Rhône Alpes region, & SNCF - Gares and connnections to innovate and invent new services in the train station.
3 days of collaborative innovation, design of service and construction of a real functional prototype, inside the Lyon St Paul train station.
Part of the "Lampistes" team, we built a funny interactive compost and recycle bin, fostering the touristic development of the area served by the station, and creating social link in the…
Gareremix is a project organized by GrandLyon, Rhône Alpes region, & SNCF - Gares and connnections to innovate and invent new services in the train station.
3 days of collaborative innovation, design of service and construction of a real functional prototype, inside the Lyon St Paul train station.
Part of the "Lampistes" team, we built a funny interactive compost and recycle bin, fostering the touristic development of the area served by the station, and creating social link in the district.
Other creators

Jan 2016 - Jun 2016

Lead organizer for the first French Startup Weekend for Medtechs.
The event will be held at the ECAM School in Lyon on June 3-4-5th 2016.
Feel free to contact me if you want to be a sponsor, mentor or judge for this Startup weekend.
Other creators

Honors & Awards

-

Apr 2018

-

Nov 2017

-

Oct 2017

lyon start-up

Dec 2016

French Tech

Jul 2016

-

Languages

Full professional proficiency

Native or bilingual proficiency

Organizations

Co-founder

Jun 2015 - Jun 2017
ExponentialMed's aim is to federate the MedTech community. We want Doctors to meet investors and entrepreneurs such as new devices & services can emerge quickly.

Ambassador

Jan 2015 - Jan 2017
BeyondLab (non-profit organization) connects researchers and entrepreneurs in MedTech, BioTech, CleanTech and IT.

Founder

May 2008 - Jan 2015
OSE is a French organization offering marketing compaigns with "flash-mobs" to companies, using mainly social networks. OSE was a non profit organization, and a fascinating work for me and my team. Our ambitious work led OSE to the first rank in France for this kind of marketing.

Recommendations received

More activity by Benjamin

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Benjamin Cohen in United States

546 others named Benjamin Cohen in United States are on LinkedIn

See others named Benjamin Cohen

Add new skills with these courses